Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1977 Jun;59(6):1188-95.
doi: 10.1172/JCI108743.

Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells

Structural features of Salmonella typhimurium lipopolysaccharide required for activation of tissue factor in human mononuclear cells

F R Rickles et al. J Clin Invest. 1977 Jun.

Abstract

Activation of mononuclear cell tissue factor was examined utilizing lipopolysaccharides obtained from wild-type and both Rc and Re mutants of Salmonella typhimurium. Wild-type (smooth) lipopolysaccharide, galactose-deficient (Rc) lipopolysaccharide, heptose-deficient (Re) lipopolysaccharide, and lipid A preparations were all active in their ability to generate tissue factor activity in human mononuclear cells grown in tissue culture. Polymyxin B has been reported to prevent some of the lethal effects of endotoxin in vivo, and the drug reportedly binds to the 2-keto-3-deoxyoctulosonate-lipid A region of the lipopolysaccharide molecule. Polymyxin B was effective in inhibiting the tissue factor generating activity of wild-type lipopolysaccharide, Re lipopolysaccharide, and lipid A in a dose-dependent fashion. Treatment of lipid A preparations with mild alkali abolished the ability of these preparations to activate tissue factor in cells. Analogous to many of the other biologic properties of lipopolysaccharide, tissue factor activation in human mononuclear cells appears to depend upon the integrity of the lipid A portion of the molecule.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Immunol. 1975 Jan;114(1 Pt 2):360-4 - PubMed
    1. J Immunol. 1975 Jan;114(1 Pt 2):377-87 - PubMed
    1. Int Arch Allergy Appl Immunol. 1975;49(1-2):1-43 - PubMed
    1. Br J Haematol. 1975 Jul;30(3):311-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1962 Oct 15;48:1831-8 - PubMed

Publication types